A Phase II Study of Ensifentrine in Non-Cystic Fibrosis Bronchiectasis

PHASE2RecruitingINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

September 11, 2024

Primary Completion Date

September 30, 2026

Study Completion Date

September 30, 2026

Conditions
Non-cystic Fibrosis Bronchiectasis
Interventions
DRUG

Nebulized Ensifentrine Suspension; 3 mg

Administered by a standard jet nebulizer, twice daily for a minimum of 24 weeks and up to a maximum of 156 weeks (3 years)

DRUG

Nebulized Placebo Solution

Administered by a standard jet nebulizer, twice daily for a minimum of 24 weeks and up to a maximum of 156 weeks (3 years)

Trial Locations (47)

10016

RECRUITING

NYU Langone Health Pulmonary and Critical Care Associates, P.C. - BRANY - PPDS, New York

15006

RECRUITING

Hospital Universitario A Coruña, A Coruña

19140

RECRUITING

Temple University Hospital, Philadelphia

20007

RECRUITING

MedStar Georgetown University Hospital, Washington D.C.

20122

RECRUITING

Istituto Clinico Humanitas, Rozzano

20900

RECRUITING

Fondazione IRCCS San Gerardo dei Tintori, Monza

23188

RECRUITING

TPMG Clinical Research, Williamsburg

27100

RECRUITING

Fondazione IRCCS Policlinico San Matteo, Pavia

27103

RECRUITING

Southeastern Research Center, Winston-Salem

27514

RECRUITING

University of North Carolina, Chapel Hill

28009

RECRUITING

Hospital General Universitario Gregorio Marañon, Madrid

28046

RECRUITING

Hospital Universitario La Paz - PPDS, Madrid

28223

RECRUITING

Hospital Universitario Quironsalud Madrid, Madrid

28401

RECRUITING

Accellacare of Wilmington, Wilmington

29425

RECRUITING

Medical University of South Carolina (MUSC) - PPDS, Charleston

30342

RECRUITING

Emory University at Saint Joseph Pulmonary Clinic, Atlanta

30912

RECRUITING

Augusta University, Augusta

33136

RECRUITING

University of Miami, Miami

35233

RECRUITING

Kirklin Clinic of UAB Hospital, Birmingham

37067

RECRUITING

Clinical Trials Center of Middle Tennessee, Franklin

40138

RECRUITING

IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna

46324

RECRUITING

ASHA Clinical Research, Hammond

48109

RECRUITING

University of Michigan Hospital, Ann Arbor

52242

RECRUITING

University of Iowa, Iowa City

55905

RECRUITING

Mayo Clinic, Rochester

63110

RECRUITING

Washington University School of Medicine, St Louis

66160

RECRUITING

University of Kansas Medical Center-Kansas City, Kansas City

75708

RECRUITING

UT Texas Health Science at Tyler, Tyler

80206

RECRUITING

National Jewish Health Main Campus, Denver

90048

RECRUITING

So Cal Institute for Respiratory Diseases, Inc., Los Angeles

95123

RECRUITING

AOU Policlinico Gaspare Rodolico-San Marco Presidio Ospedaliero Gaspare Rodolico, Catania

95817

RECRUITING

University of California Davis Medical Center, Sacramento

97239

RECRUITING

Oregon Health and Science University, Portland

02114

RECRUITING

Massachusetts General Hospital- 55 Fruit St, Boston

08003

RECRUITING

Hospital del Mar, Barcelona

08036

RECRUITING

Hospital Clinic de Barcelona, Barcelona

RECRUITING

Hospital Universitario Vall d'Hebron - PPDS, Barcelona

08907

RECRUITING

Hospital Universitario de Bellvitge, Barcelona

DD1 9SY

RECRUITING

Ninewells Hospital - PPDS, Dundee

G12 0YN

RECRUITING

Queen Elizabeth University Hospital - PPDS, Glasgow

B9 5SS

RECRUITING

Birmingham Heartlands Hospital, Birmingham

BT9 7AB

RECRUITING

Queens Hospital Belfast, Belfast

CB2 0AY

RECRUITING

Royal Papworth Hospital, Cambridge

EH16 4SA

RECRUITING

Royal Infirmary of Edinburgh - PPDS, Edinburgh

L14 3PE

RECRUITING

Liverpool Heart and Chest Hospital - PPDS, Liverpool

SW3 6HP

RECRUITING

Royal Brompton Hospital, London

NE7 7DN

RECRUITING

Freeman Hospital, Newcastle-under-Lyme

All Listed Sponsors
lead

Verona Pharma plc

INDUSTRY